• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新加坡注射吸毒早期阶段的静脉注射阿片类药物使用者丙型肝炎血清流行率。

Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.

作者信息

Winslow M, Subramaniam M, Ng W L, Lee A, Song G, Chan Y H

机构信息

Community Addictions Management Programme, Institute of Mental Health and Woodbridge Hospital, Singapore.

出版信息

Singapore Med J. 2007 Jun;48(6):504-8.

PMID:17538746
Abstract

INTRODUCTION

All over the world, Hepatitis C virus (HCV) accounts for an estimated 130 million chronic infections. Injection drug use has become one of the most important risk factors for HCV, and within the injection drug user population, the prevalence of HCV antibody ranges from 70 to 95 percent depending on an individual's length of use and the prevalence of infection in the community. This study was undertaken to determine the prevalence of and the risk factors for Hepatitis C antibodies in injecting drug users presenting to the Community Addictions Management Programme (CAMP) in Singapore.

METHODS

Eligibility criteria for inclusion in this study were all intravenous buprenorphine users presenting to CAMP. 106 subjects, who consented to the study, completed an interviewer-administered questionnaire, and underwent a urine and blood analysis.

RESULTS

The prevalence rate for HCV was 42.5 percent among the subjects included in our study. The odds of seroprevalence in those sharing needles were 5.6 times that of those who were not, and the odds of seroprevalence among those using with others (peers or partners) were 6.3 times, as compared to among those who were individual users. Racial differences were also seen, but these could be accounted for by the sharing of needles.

CONCLUSION

This study provides important local data at the onset of an early buprenorphine-injecting epidemic in Singapore. This data is useful for disease prevention and healthcare planning.

摘要

引言

在全球范围内,丙型肝炎病毒(HCV)估计导致了1.3亿例慢性感染。注射吸毒已成为感染HCV最重要的风险因素之一,在注射吸毒人群中,HCV抗体的流行率在70%至95%之间,这取决于个人的使用时长以及社区中的感染流行率。本研究旨在确定前往新加坡社区成瘾管理项目(CAMP)的注射吸毒者中丙型肝炎抗体的流行率及其风险因素。

方法

纳入本研究的合格标准为所有前往CAMP的静脉注射丁丙诺啡使用者。106名同意参与研究的受试者完成了一份由访谈员填写的问卷,并接受了尿液和血液分析。

结果

在我们研究纳入的受试者中,HCV的流行率为42.5%。共用针头者的血清阳性率几率是非共用者的5.6倍,与独自使用者相比,与他人(同伴或伴侣)一起使用毒品者的血清阳性率几率是其6.3倍。还观察到了种族差异,但这些差异可由共用针头来解释。

结论

本研究在新加坡早期丁丙诺啡注射流行开始时提供了重要的本地数据。这些数据对疾病预防和医疗保健规划很有用。

相似文献

1
Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.新加坡注射吸毒早期阶段的静脉注射阿片类药物使用者丙型肝炎血清流行率。
Singapore Med J. 2007 Jun;48(6):504-8.
2
Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.新西兰注射吸毒人群中的注射行为以及乙肝、丙肝和丁肝标志物的流行情况。
N Z Med J. 1998 Feb 27;111(1060):50-3.
3
Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.参与美沙酮项目的注射吸毒者中丙型肝炎血清流行率。
N Z Med J. 1995 Sep 8;108(1007):364-6.
4
Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.注射吸毒者自我宣称的非注射性伴侣中的丙型肝炎病毒
J Med Virol. 2004 Sep;74(1):62-6. doi: 10.1002/jmv.20146.
5
Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.伦敦和格拉斯哥近期开始注射毒品者中丙型肝炎病毒感染的患病率及危险因素:横断面分析
J Viral Hepat. 2005 Nov;12(6):655-62. doi: 10.1111/j.1365-2893.2005.00643.x.
6
Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.有证据表明,除注射器/针头外,共用注射器具在注射吸毒者中丙型肝炎传播方面起到了重要作用。
J Viral Hepat. 2006 Aug;13(8):560-70. doi: 10.1111/j.1365-2893.2006.00725.x.
7
Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.荷兰阿姆斯特丹年轻吸毒者中丙型肝炎病毒感染的风险行为变化及动态情况。
J Med Virol. 2005 Dec;77(4):509-18. doi: 10.1002/jmv.20486.
8
[Risk factors for hepatitis C among injecting drug users in Oslo].[奥斯陆注射吸毒者中丙型肝炎的危险因素]
Tidsskr Nor Laegeforen. 2009 Jan 15;129(2):101-4. doi: 10.4045/tidsskr.09.35002.
9
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.1994 - 2004年美国注射吸毒者中丙型肝炎病毒感染的患病率。
Clin Infect Dis. 2008 Jun 15;46(12):1852-8. doi: 10.1086/588297.
10
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.接受阿片类药物替代疗法的注射吸毒者中丙型肝炎病毒的流行情况及转归
J Gastroenterol Hepatol. 2005 Jul;20(7):1082-6. doi: 10.1111/j.1440-1746.2005.03882.x.

引用本文的文献

1
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.经常注射丁丙诺啡的人群的使用模式和报告的不良事件:系统评价。
Harm Reduct J. 2022 Oct 13;19(1):113. doi: 10.1186/s12954-022-00695-5.
2
What is required for achieving hepatitis C virus elimination in Singapore? A modeling study.在新加坡实现丙型肝炎病毒消除需要什么?一项建模研究。
J Gastroenterol Hepatol. 2021 Apr;36(4):1110-1117. doi: 10.1111/jgh.15211. Epub 2020 Sep 3.
3
Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.
直接准入转诊的床边丙型肝炎筛查提高中途之家居民的护理衔接:一项试点随机研究。
Singapore Med J. 2022 Feb;63(2):86-92. doi: 10.11622/smedj.2020116. Epub 2020 Jul 30.
4
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.亚太地区的肝脏疾病:《柳叶刀·胃肠病学和肝脏病学》专刊。
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228. doi: 10.1016/S2468-1253(19)30342-5. Epub 2019 Dec 15.
5
Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.献血者和高危人群中丙型肝炎病毒感染及IL28B基因多态性的患病率
Singapore Med J. 2019 Jan;60(1):34-39. doi: 10.11622/smedj.2018078. Epub 2018 Jun 21.
6
Burden of blood transmitted infections in substance users admitted for inpatient treatment in Singapore and the associated factors.新加坡住院治疗的药物使用者中血液传播感染的负担及相关因素。
Singapore Med J. 2015 Feb;56(2):87-91. doi: 10.11622/smedj.2014199.
7
Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis.利用多参数证据综合法填补马来西亚丙型肝炎病毒感染流行病学中的数据空白。
BMC Infect Dis. 2014 Nov 7;14:564. doi: 10.1186/s12879-014-0564-6.
8
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.在马来西亚市场引入丁丙诺啡/纳洛酮复方制剂后,丁丙诺啡注射液的使用量未减。
Am J Drug Alcohol Abuse. 2009;35(2):68-72. doi: 10.1080/00952990802585406.